Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 16 Oct 2024

Comprehensive analysis of lactylation-related gene sets and mitochondrial functions in gastric adenocarcinoma: implications for prognosis and therapeutic strategies

in Cancer Immunity and Immunotherapy

Xindong Yin
Wenya Xing
Nan Yi
Yuanzi Zhou
Yue Chen
Zhiwei Jiang
Chaoqun Ma
Cunbing Xia

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451725

5,105 views
1 citation

Original Research

Published on 16 Oct 2024

Explore the expression of mitochondria-related genes to construct prognostic risk model for ovarian cancer and validate it, so as to provide optimized treatment for ovarian cancer

in Cancer Immunity and Immunotherapy

Zheng Yunyun
Wang Guihu
Jiang An

Frontiers in Immunology

doi 10.3389/fimmu.2024.1458264

1,861 views
1 citation

Editorial

Published on 16 Oct 2024

Editorial: Immunobiology and immunotherapeutics in myelodysplastic syndrome and acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Shyam A. Patel
Alessandro Isidori
Claudio Cerchione
Anna Aureli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500864

562 views

Systematic Review

Published on 16 Oct 2024

Impact of combinatorial immunotherapies in breast cancer: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Sandeep Sisodiya
Vishakha Kasherwal
Jyoti Rani
Neetu Mishra
Sandeep Kumar
Asiya Khan
Mehreen Aftab
Shagufta
Payal Singh
Ekta Gupta

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469441

1,893 views

Original Research

Published on 16 Oct 2024

The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer

in Cancer Immunity and Immunotherapy

Wenzhe Li
Da Ke
Yi Xu
Ya Wang
Qian Wang
Jie Tan
Hongyan Wu
Xianglin Cheng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1464421

1,939 views

Original Research

Published on 16 Oct 2024

Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening

in Cancer Immunity and Immunotherapy

Siyu Zhang
Changxin Huang
Yongqiang Li
Zhaoyang Li
Ying Zhu
Lili Yang
Haokun Hu
Quan Sun
Mengmeng Liu
Songqiang Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1473145

1,687 views
1 citation

Systematic Review

Published on 16 Oct 2024

Efficacy and safety of natural killer cell therapy in patients with solid tumors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Heesook Park
Gyurin Kim
Najin Kim
Sungyoen Ha
Hyeonwoo Yim

Frontiers in Immunology

doi 10.3389/fimmu.2024.1454427

3,514 views
1 citation

Brief Research Report

Published on 16 Oct 2024

LIN28 upregulation in primary human T cells impaired CAR T antitumoral activity

in Cancer Immunity and Immunotherapy

Patricia Garcia-Rodriguez
Laura Hidalgo
Miguel Angel Rodriguez-Milla
Beatriz Somovilla-Crespo
Javier Garcia-Castro

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462796

1,446 views
1 citation

Original Research

Published on 15 Oct 2024

Type I-conventional dendritic cells support the progression of multiple myeloma in the bone marrow

in Cancer Immunity and Immunotherapy

Sayaka Suzuki
Kazuma Komiya
Shogo Tsuda
Miya Yoshino
Tsuneyasu Kaisho
P. Leif Bergsagel
Koji Kawamura
Tetsuya Fukuda
Koji Tokoyoda

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444821

1,853 views

Original Research

Published on 15 Oct 2024

Single-cell and spatial transcriptome characterize coinhibitory cell-cell communications during histological progression of lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Judong Luo
Qianman Gao
Meihua Wang
Hui Liu
Hong Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430163

2,186 views
1 citation

Case Report

Published on 15 Oct 2024

Case report: The impact of dissociated response of immunotherapy on the treatment strategy of advanced head and neck cancer

in Cancer Immunity and Immunotherapy

Siqing Jiang
Xin Li
Jin Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1460480

912 views

Original Research

Published on 15 Oct 2024

Prognostic value of T regulatory cells and immune checkpoints expression in tumor-draining lymph nodes for oral squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Krzysztof Piersiala
Eric Hjalmarsson
Vilma Lagebro
Pedro Farrajota Neves da Silva
Rusana Bark
Alexandra Elliot
Linda Marklund
Gregori Margolin
Susanna Kumlien Georén
Lars-Olaf Cardell

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455426

1,613 views
1 citation

Original Research

Published on 15 Oct 2024

Making the effect visible – OX40 targeting nanobodies for in vivo imaging of activated T cells

in Cancer Immunity and Immunotherapy

Desiree I. Frecot
Simone Blaess
Teresa R. Wagner
Philipp D. Kaiser
Bjoern Traenkle
Madeleine Fandrich
Meike Jakobi
Armin M. Scholz
Stefan Nueske
Nicole Schneiderhan-Marra

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480091

1,814 views

Original Research

Published on 15 Oct 2024

Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response

in Cancer Immunity and Immunotherapy

Patrick Santos
Caroline P. Rezende
Renan Piraine
Bianca Oliveira
Francielle B. Ferreira
Vinicius S. Carvalho
Rodrigo T. Calado
Matteo Pellegrini
Fausto Almeida

Frontiers in Immunology

doi 10.3389/fimmu.2024.1468229

2,136 views

Original Research

Published on 15 Oct 2024

PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop

in Cancer Immunity and Immunotherapy

Noor Abdala-Saleh
Jennie Lugassy
Akshatha Shivakumar-Kalvhati
Abeer Turky
Sari Abu Ras
Hila Razon
Nir Berger
Dana Bar-On
Yotam Bar-On
Tetsuya Taura

Frontiers in Immunology

doi 10.3389/fimmu.2024.1452212

1,861 views

Original Research

Published on 15 Oct 2024

Bibliometric and visualized analysis on global trends and hotspots of TAK1 in regulated cell death: 1999 to 2024

in Cancer Immunity and Immunotherapy

Kun Huang
Ye He
Hao Wan
Xiao-Xia Ban
Xin-Yu Chen
Xi-Min Hu
Xin-Xing Wan
Rui Lu
Qi Zhang
Kun Xiong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1437570

1,981 views

Navigation group

Articles

Comprehensive analysis of lactylation-related gene sets and mitochondrial functions in gastric adenocarcinoma: implications for prognosis and therapeutic strategies

Explore the expression of mitochondria-related genes to construct prognostic risk model for ovarian cancer and validate it, so as to provide optimized treatment for ovarian cancer

Editorial: Immunobiology and immunotherapeutics in myelodysplastic syndrome and acute myeloid leukemia

Impact of combinatorial immunotherapies in breast cancer: a systematic review and meta-analysis

The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer

Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening

Efficacy and safety of natural killer cell therapy in patients with solid tumors: a systematic review and meta-analysis

LIN28 upregulation in primary human T cells impaired CAR T antitumoral activity

Type I-conventional dendritic cells support the progression of multiple myeloma in the bone marrow

Single-cell and spatial transcriptome characterize coinhibitory cell-cell communications during histological progression of lung adenocarcinoma

Case report: The impact of dissociated response of immunotherapy on the treatment strategy of advanced head and neck cancer

Prognostic value of T regulatory cells and immune checkpoints expression in tumor-draining lymph nodes for oral squamous cell carcinoma

Making the effect visible – OX40 targeting nanobodies for in vivo imaging of activated T cells

Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response

PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop

Bibliometric and visualized analysis on global trends and hotspots of TAK1 in regulated cell death: 1999 to 2024